Login
Register
Submit a Paper
Propose a Special lssue
Open Access
REVIEW
Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, USA
* Address correspondence to: Wenjuan Li,
BIOCELL 2020, 44(2), 127-135. https://doi.org/10.32604/biocell.2020.010018
Received 04 February 2020; Accepted 08 April 2020; Issue published 27 May 2020
Download PDFAbstract
From late December 2019 a new human-adapted coronavirus, SARS-CoV-2, was observed and isolated in clustered patients in Wuhan, China. It has been proved to be able to transmit human-to-human and cause pneumonia, leading to about 2% fatality. Its genome characteristics, immune responses and related potential treatments, such as chemical drugs, serum transfusion and vaccines including DNA vaccines, are discussed in this review for a brief summary.Keywords
Cite This Article
APA Style
LI, W., SONG, G. (2020). Updated thoughts on sars-cov-2 and coronavirus therapies, fighting and surviving. BIOCELL, 44(2), 127-135. https://doi.org/10.32604/biocell.2020.010018
Vancouver Style
LI W, SONG G. Updated thoughts on sars-cov-2 and coronavirus therapies, fighting and surviving. BIOCELL . 2020;44(2):127-135 https://doi.org/10.32604/biocell.2020.010018
IEEE Style
W. LI and G. SONG, "Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving," BIOCELL , vol. 44, no. 2, pp. 127-135. 2020. https://doi.org/10.32604/biocell.2020.010018
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
